Laidlaw acts as Sole-Book Runner on the $3,500,000 BioSig Technologies’...
Laidlaw Capital Markets is pleased to have acted as Sole-Book Runner on the $3,500,000 Common Stock transaction for BioSig Technologies (BSGM). Read Article
View ArticleLaidlaw Capital Markets is pleased to announce the closing of its expanded...
Perfect Moment is a luxury sportswear brand that has become known as an iconic staple in winter wear. The Perfect Moment collections marry the extreme demands of nature with the world of fashion and...
View ArticleLaidlaw acts as Sole Book-Runner on the $5,750,000 Silo Pharma, Inc....
Silo Pharma Announces Closing of $5.75 Million Public Offering of Common Stock, Nasdaq Listing, and Full Exercise of Underwriter’s Over-Allotment Option: Read Article
View ArticleLaidlaw acts as Sole Placement Agent on the $4,000,000 NLS Pharmaceutics Ltd....
Laidlaw is pleased to have acted as the Sole Placement Agent on the $4,000,000 Private Placement for NLS Pharmaceutics. Read Article
View ArticleLaidlaw acts as Exclusive Introducing Broker on NLS Pharmaceutics’ Closing of...
On December 14, 2022, NLS Pharmaceutics (NASDAQ:NLSP,)(NASDAQ:NLSPW) announced the closing of its previously publicized purchase agreement with BVF Partners L.P. ("BVF") comprised of an initial closing...
View ArticleLaidlaw acts as Co-Manager on the $287,500,000 Follow-On Offering for Viking...
Laidlaw is pleased to act as Co-Manager on Vikings 287.5mm dollar offering. Laidlaw Capital Markets was the Sole Book Runner on Viking’s 27.6mm dollar IPO in 2015. VKTX is now over a one billion dollar...
View ArticleLaidlaw served as Co-Manager on the $129,000,000 Common Stock and Concurrent...
Laidlaw served as Co-Manager on the $129,000,000 Common Stock and Concurrent Private Placement for Soleno Therapeutics (SLNO)
View ArticleEyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and...
EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
View ArticleLaidlaw acts as Underwriter on the $367,886,900 Cohen & Steers Real Estate...
Laidlaw Capital Markets is pleased to have acted as Underwriter on the $367,886,900 Cohen & Steers Real Estate Opportunities and Income Fund Offering alongside Bank of America, Morgan Stanley,...
View ArticleLaidlaw’s James Ahern Named to Crain’s New York Notable Leaders in Finance 2024
EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
View Article
